Financial statements Avi-Pharma
Balance sheet data of AVI-PHARMA
Year
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|
Total assets | 8 110,10 | 5 304,90 | 54 246,04 | 393 912,32 |
A. Fixed assets | 2 000,00 | 1 000,00 | 34 000,00 | 33 207,64 |
B. Current assets | 6 110,10 | 4 304,90 | 20 246,04 | 360 704,68 |
C. Share capital contributions (basic funds) | - | - | - | - |
D. Own shares (stocks) | - | - | - | - |
Total liabilities | 8 110,10 | 5 304,90 | 54 246,04 | 393 912,32 |
A. Equity | 7 925,60 | 5 116,52 | -267,23 | -95 325,52 |
B. Liabilities and provisions for liabilities | 184,50 | 188,38 | 54 513,27 | 489 237,84 |
I. Long-term liabilities | 0,00 | 0,00 | 50 000,00 | 400 000,00 |
II. Short-term liabilities | 184,50 | 188,38 | 4 513,27 | 89 237,84 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.